Andrew Loh

Mar 15, 2024 | bcg.com | Andrew Loh |Aakash Arora |Brian Collie

BCG research found that 70% of US consumers are considering buying an electric vehicle. Can OEMs meet the price and performance needs of these potential customers while still making a profit? Despite recent setbacks, the US remains a big potential market for EVs: beyond the 6% who already own an EV, 38% of consumers say they plan to purchase an EV as their next vehicle, and 27% are considering doing so in the future.

Feb 12, 2024 | medium.com | Andrew Loh

While the ClimateTech industry continues to go from strength-to-strength, it is essential to acknowledge a hard truth. Most ClimateTech founders can’t access venture capital. Why? Traditional venture capital fits within a tight box: you either fit into the profile of producing 10x returns within 5–10 years or you don’t. Many ClimateTech startups are building hardware solutions — tangible products aimed at addressing the physical challenges of the climate crisis.

Jul 11, 2023 | medium.com | Andrew Loh

Terms like "carbon-neutral" or "net-zero" may also be used to typically signify sustainability ambitions without demonstrating tangible actions or producing concrete results.

Apr 27, 2023 | medium.com | Andrew Loh

Let's make this clear. I am an investor and it's unlikely I'll find my next billion dollar investment at a startup pitch night. Especially this year. Uncertain economic conditions have brought a seemingly destabilised investment landscape and the venture capital market has not been immune to its effects. The Australian Startup Community is stronger than ever. But, I don't see it that way. Attending pitch nights allows me to engage with the startup ecosystem.

Apr 24, 2023 | bcg.com | Andrew Loh

Medical devices are vastly more sophisticated today than they were a decade ago. They are increasingly digitized and able to capture, process, and communicate far more information, leading to better efficiency and improved outcomes for patients, providers, and health care systems. However, innovation and development processes for medical technology (medtech) products have not kept pace.